Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
11/2005
11/16/2005EP1450782B1 Use of a combination composition comprising propionyl l-carnitine and further drugs for the treatment of erectile dysfunction
11/16/2005EP1363631A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/16/2005EP1363608B1 Formulations comprising ibuprofen and diphenhydramine and the use thereof for the treatment of sleep disturbances
11/16/2005EP1294927B1 Screening-method for modulators of methyltransferase-dependent chromosome stability
11/16/2005EP1114052B1 4-aminopyrrolopyrimidines as kinase inhibitors
11/16/2005EP0904099B1 Pharmaceutical formulation containing human growth hormone, histidine and a non-ionic detergent
11/16/2005CN1697828A New compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
11/16/2005CN1227354C Combination of lactic acid bacteria and its use for prevention and/or treatment of infections and inflammatory conditions
11/16/2005CN1227241C Arylpiperazines having activity at the serotnin 1A receptor
11/16/2005CN1227237C Piperazinylpyrazines compounds as antagonists of serotonin-5-HT2 receptor
11/16/2005CN1227233C 5-chloro-3-(4-methane sulfonylphenyl)-6-methyl-[2,3'] bipyridine and process for synthesis
11/16/2005CN1227017C Chinese medicine for health of women in menstrual period
11/15/2005US6964978 Dissolving with crystal growth inihibitos; drying
11/15/2005US6964973 Nonsteroidal agonists and antagonists
11/15/2005US6964972 8-Azabicyclo(3,2,1)oct-2 ene and octane derivatives as cholinergic ligands at nicotinic ACh receptors
11/15/2005US6964965 Corticotropin releasing factor antagonists
11/15/2005US6964962 A norepinephrine reuptake inhibitor or its salt and a neuroleptic agent
11/15/2005US6964955 Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol
11/15/2005US6964780 Phosphodiesterase inhibitor; therapy for sexual disorders; sildenafil in polyoxyethylene glycol enteric coating
11/15/2005CA2387517C Novel biaryl ether derivatives useful as monoamine reuptake inhibitors
11/15/2005CA2130944C Ortho-substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
11/15/2005CA2130031C Urea-substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
11/10/2005WO2005105103A2 Management of breakthrough bleeding in extended hormonal contraceptive regimens
11/10/2005US20050250846 Non-peptide GnRH agents, pharmaceutical compositions and methods for their use
11/10/2005US20050250834 11-(Aminoalkyl)isoindolo[2,1-a]indol-6-ones: 11-(2-Dimethylaminoethyl)-2-fluoroisoindolo[2,1-a]indol-6-one; psychological disorders, drug abuse, sleep disorders, Alzheimer's, Parkinson's and Huntington's disease, Irritable bowel syndrome, chemotherapy induced emesis, spinal trauma and/or head injury
11/10/2005US20050250793 Preventives/remedies for hot flash
11/10/2005US20050250747 Management of breakthrough bleeding in extended hormonal contraceptive regimens
11/10/2005US20050250716 Immunostimulatory oligodeoxynucleotides
11/10/2005US20050250689 Antagonists for human prolactin
11/10/2005US20050250167 Purified pkb ser 473 kinase and uses thereof
11/10/2005US20050249722 Monoclonal antibodies with enhanced ADCC function
11/10/2005CA2565626A1 Compositions for progeny gender control
11/10/2005CA2563963A1 3-heterocyclyl-4-phenyl-triazole derivatives as inhibitors of the vasopressin v1a receptor
11/10/2005CA2562296A1 Management of breakthrough bleeding in extended hormonal contraceptive regimens
11/09/2005EP1593683A2 Dihydro-2,3-Benzodiazepine derivatives
11/09/2005EP1593387A1 Compositions for the treatment of impaired interpersonal and behavioral disorders
11/09/2005EP1592693A1 Benzamide derivatives as oxytocin agonists and vasopressin antagonists
11/09/2005EP1592431A1 Method of modulating il-6
11/09/2005EP1592389A2 Piperazine-2-carboxamide derivatives
11/09/2005EP1427734B1 GLYCINE-SUBSTITUTED THIENO[2,3-d]PYRIMIDINES WITH COMBINED LH AND FSH AGONISTIC ACTIVITY
11/09/2005EP1405083B1 Natural ligand of gpcr chemr23 and uses thereof
11/09/2005EP1377585B1 Novel 10-cyclohexenyl-phenyl pyrrolobenzodiazepine-3-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists
11/09/2005EP1315714B1 Quinazoline derivatives as alpha-1 adrenergic antagonists
11/09/2005EP1313700B1 10-aryl-11h-benzo[b]fluorene derivatives and analogs as estrogenic compounds
11/09/2005EP1278729B1 Benzosuberonylpiperidine compounds as analgesics
11/09/2005EP1259514B9 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
11/09/2005EP1220932B1 Human carboxypeptidases and polynucleotides encoding the same
11/09/2005EP1189605B1 High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof
11/09/2005EP1095016B1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
11/09/2005EP0792162B1 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria
11/09/2005CN1694900A EE3-protein family and corresponding DNA sequences
11/09/2005CN1694879A Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same
11/09/2005CN1694864A N-bridged selective androgen receptor modulators and methods of use thereof
11/09/2005CN1694736A Medical devices containing rapamycin analogs
11/09/2005CN1694707A Pde-v inhibitor and medicine composite with active agent
11/09/2005CN1226304C Methylene steroids as novel androgens
11/09/2005CN1226037C Use of sucralfate for the treatment of cervical erosion
11/08/2005US6962988 Comprises deiminase polypeptide for sterilization of female animals and/or the generation of antibodies useful for temporary, reversible contraception
11/08/2005US6962969 Compounds and methods for modulating nonclassical cadherin-mediated functions
11/08/2005US6962928 such as 6-methoxy-2-(4-methoxyphenyl)-1-[4-(2-piperidin-1-yl-ethyoxy)-phenyl]-1,2,3,4-tetrahydroquinoline
11/08/2005US6962923 Pyrazole compositions
11/08/2005US6962919 Gonadotropin-releasing hormone antagonizing activity; useful as prophylactic or therapeutic agent for sex hormone-dependent diseases
11/08/2005US6962918 Hexahydropyrazino[1'2';1,6]pyrido[3,4-b]indole-1,4-diones for the treatment of cardiovascular disorders and erectile dysfunction
11/08/2005US6962911 Treatment of impotence, sexual dysfunction in female, stable, unstable and variant angina, hypertension, pulmonary hypertension, congestive heart failure, atherosclerosis
11/08/2005US6962908 Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
11/03/2005US20050245602 Selective estrogen receptor modulators
11/03/2005US20050245567 Novel quinuclidine derivatives and their use
11/03/2005US20050245553 Amino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl chloromethanesulfonate; cardiovascular disorders, thromboembolic disorders, inflammation, and disorders of the central nervous system
11/03/2005US20050245545 administering a xanthine derivative such as (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine
11/03/2005US20050245537 Use of compounds having ccr antagonism
11/03/2005US20050245520 2-Phenylpyridin-4-yl derivatives as alk5 inhibitors
11/03/2005US20050245496 Mixture with carrier; dosage units; prevent ovulation; immonomoderator
11/03/2005US20050245486 Prostate specific membrane antigen (PSMA); for diagnosis, detection and treatment of cancer; gene overexpression; kits
11/03/2005US20050245455 Gonadotropin releasing hormone antagonists in gel-forming concentrations
11/03/2005CA2802600A1 Use of flibanserin in the treatment of female sexual disorders
11/03/2005CA2563743A1 New pharmaceutical compositions for the treatment of sexual disorders ii
11/03/2005CA2562571A1 Novel androgens
11/02/2005EP1591446A1 Thienopyrimidine compounds and use thereof
11/02/2005EP1591129A2 Use of neurotoxic component of botulinum toxin for treating pain associated with cervical dystonia or bepharospasm
11/02/2005EP1591115A1 Preventive or remedy for intrauterine late embryonic development or pregnancy toxemia
11/02/2005EP1590668A2 Screeninig and treatment methods for prevention of preterm delivery
11/02/2005EP1589976A1 Compositon comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometriosis
11/02/2005EP1501515B1 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/02/2005EP1357930B1 Histidine-rich glycoprotein (hrgp) for inhibiting angiogenesis
11/02/2005EP1296691B1 Use of cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infections
11/02/2005EP1237902B1 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase
11/02/2005EP1177190B1 USE OF SELECTIVE ANTAGONISTS OF THE ALPHA 1b-ADRENERGIC RECEPTOR FOR IMPROVEMENT OF SEXUAL DYSFUNCTION
11/02/2005EP1102767B1 Substituted pyrazole derivatives
11/02/2005EP1083905B1 Medical use of a selective estrogen receptor modulator in combination with a sex steroide precursor
11/02/2005EP1009414B1 Novel pharmaceutical composition comprising clindamycin and clotrimazol for the treatment of vaginal infections
11/02/2005CN1692122A New etonogestrel esters
11/02/2005CN1691958A Enos mutants useful for gene therapy
11/02/2005CN1691957A 蛋白酶抑制剂 Protease inhibitors
11/02/2005CN1225271C Medicine for treating hyperplasia disease of mamary glands
11/02/2005CN1225239C Fimbriate orostachys herb suppository and its preparing process
11/01/2005US6960661 [7-(3-chloro-4-methoxybenzlamino)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-ylmethoxy]acetic acid, synthesis thereof and intermediates used therein
11/01/2005US6960602 Piperidine derivatives as modulators of chemokine receptors
11/01/2005US6960601 Imidazole derivatives; appetite suppressants
11/01/2005US6960599 Dopamine D2 receptor and 5-HT1A antagonists; schizophrenia; cognitive activators; Alzheimer's disease; brain disorders; strokes; antiischemic agents; anxiolytic agents; obsessive compulsive disorder; eating, sleeping and sexual disorders
11/01/2005US6960592 erectile dysfunction; halosulfonation of 2-ethoxy benzoic acid, sulfonamidation, haloacylation, deacylation and amidation, cyclization; phosphodiesterase inhibitor; side-effect reduction; long lasting
1 ... 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 ... 557